Federal Drug Development Programs

GAO compiled information on the federal government's involvement in drug development programs to assist Congress in its consideration of the federal role in developing orphan drugs. GAO reported on federal controls over development and marketing of drugs and described federal drug development, highlighting the basis of government involvement, the scope of their activities, the status of drug development in these programs, and some factors to consider in establishing new drug development programs.